CYP26A1 and colorectal carcinoma: Because the CYP26A1 inhibitor liarozole is able to decrease the proliferation of CRC cells (discussed above), we also treated CRC cells with liarozole, to determine the effects of CYP26A1 inhibition on sphere formation and SC numbers.